Invetech, Vaxxas awarded 2015 Good Design Award for needle-free technology

Invetech and Vaxxes awarded for Nanopatch needle-free drug delivery
Invetech and Vaxxes awarded for Nanopatch needle-free drug delivery | Courtesy of medicalexpo.com

Invetech, a leading company focusing on custom automation, instrument development and contact manufacturing, and Vaxxas, a biotechnology start-up best known for developing the needle-free drug delivery technology known as Nanopatch, recently won the 2015 Good Design Award for creating the Nanopatch Jet Coating Instrument.

This innovative needle-free drug delivery technology was created with an advanced technology platform for needle-free dermal drug delivery research and development. 

"Our collaboration with Vaxxas is a great demonstration of how Invetech can complement the important work of emerging leaders in medical technology with additional insight and know-how to address very specific and complex challenges," Richard Grant, global vice president at Invetech, said. "We are all very pleased that the Nanopatch Jet Coating Instrument, which represents an important milestone in drug delivery innovation, has been named the recipient of a 2015 Good Design Award."

The system uses thousands of coated microprojections to puncture the dermal layer of the skin and administer the vaccine to the skin’s outer layers. Nanopath technology is much more beneficial than traditional injections because it reduces pain, costs less than syringes, improves vaccine effectiveness and requires no refrigerated supply chain.

"Our goal with the Nanopatch has been to develop a technology that enables safer and more efficient vaccination versus administration via needle and syringe,” Dr. Angus Forster, Vaxxas' chief development and operations officer, said. “The Nanopatch has the potential to provide a better patient experience, with better overall economics because there is no need to maintain costly cold-chain. Of course, development of an advanced technology platform like this presented some challenges. With our collaboration with Invetech, we brought together the range of expertise and insight to identify a new method to apply drug to microprojections that represents a major advance in our ability to deliver vaccines to patients."

The recipients accepted the award at the Good Design Awards Gala Night which took place in Sydney, Australia.

Organizations in this Story


Want to get notified whenever we write about Invetech ?
Next time we write about Invetech, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.